The FTC has agreed to allow Amgen to buy Horizon, the manufacturer of Tepezza, after proposing a consent decree which seeks to prevent the company from gaining an overwhelming advantage…
The FTC has filed a complaint to stop Amgen from acquiring Horizon Therapeutics, saying it would give the manufacturer a monopoly on certain drugs, like Tepezza.
A Tepezza hearing damage lawsuit claims a woman suffered permanent hearing loss due to the side effects of the thyroid eye disease drug.
Horizon Pharmaceuticals is asking a federal judge to dismiss all Tepezza lawsuits over hearing loss injuries, claiming they are preempted by federal law.
A group of plaintiffs are calling for Tepezza hearing loss lawsuits to be consolidated before one Northern Illinois federal judge for pretrial proceedings.
Two investors have filed lawsuits to stop the acquisition of Tepezza manufacturer Horizon Therapeutics, claiming the company is hiding material financial projections from shareholders who must approve the deal.
Despite the threat of having to eventually pay Tepezza lawsuit payouts, Amgen has acquired the drug's manufacturer, Horizon Pharmaceuticals for nearly $30 billion.
A product liability lawsuit claims the side effects of Tepezza, a thyroid eye disease drug, led to permanent hearing loss.
